Target Name: RASSF8-AS1
NCBI ID: G100506451
Review Report on RASSF8-AS1 Target / Biomarker Content of Review Report on RASSF8-AS1 Target / Biomarker
RASSF8-AS1
Other Name(s): RASSF8 antisense RNA 1 | RASSF8 antisense RNA 1, transcript variant 1 | RASSF8-AS1 variant 1

RASSF8-AS1: A Drug Target / Disease Biomarker

RNA-Assisted Splice Affinity Purification (RASSF) is a technique that has been widely used to identify and purify RNA assays, including splice Affinity Purification (SAP) assays. RASSF8-AS1 is a specific variant of RASSF that has been shown to be particularly effective for identifying and purifying RNA assays, including those that use splice Affinity Purification (SAP) assays.

The RASSF gene family is a family of RNA-protein interactions that are involved in the regulation of gene expression. The RASSF gene family includes several different subunits, each of which has different functions in regulating gene expression.

One of the main functions of the RASSF gene family is to regulate gene expression by ensuring that RNA is properly processed and translated into proteins. This is accomplished through a variety of different mechanisms, including the regulation of splicing and the translation of RNA into proteins.

One of the key challenges in regulating gene expression is ensuring that the correct RNA is produced at the correct time and in the correct format. This is important for the proper functioning of the cell and for the development of various diseases.

splice Affinity Purification (SAP) assays are widely used as a tool for identifying and purifying RNA assays. SAP assays are used to separate RNA assays based on their splice affinity, which is the ability of RNA to form a specific splice with a specific pre-mRNA.

RASSF8-AS1 is a specific variant of RASSF that has been shown to be particularly effective for identifying and purifying RNA assays, including those that use SAP assays. RASSF8-AS1 is a splice-optimized RASSF protein that has been shown to be able to efficiently clear RNA from cells and purify RNA assays.

One of the key benefits of RASSF8-AS1 is its ability to efficiently clear RNA from cells. This is accomplished through its ability to form a covalent complex with RNA and then release it from the complex, allowing it to be purified from the cells.

Another key benefit of RASSF8-AS1 is its ability to efficiently purify RNA assays. This is accomplished through its ability to form a covalent complex with RNA and then release it from the complex, allowing it to be purified from the cells.

In addition to its ability to efficiently clear and purify RNA assays, RASSF8-AS1 has also been shown to be a good partner for a variety of different RNA assays. This is because of its specificity for SAP assays, as well as its ability to form a covalent complex with RNA.

Overall, RASSF8-AS1 is a drug target and a biomarker that has the potential to be used in a variety of different applications. Its ability to efficiently clear and purify RNA assays makes it an attractive tool for the identification and characterization of RNA assays, including those that use SAP assays. Further research is needed to fully understand the potential of RASSF8-AS1 and its potential applications in medicine.

Protein Name: RASSF8 Antisense RNA 1

The "RASSF8-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RASSF8-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RASSF9 | RAVER1 | RAVER2 | RAX | RAX2 | RB1 | RB1-DT | RB1CC1 | RBAK | RBAK-RBAKDN | RBAKDN | RBBP4 | RBBP4P2 | RBBP4P6 | RBBP5 | RBBP6 | RBBP7 | RBBP8 | RBBP8NL | RBBP9 | RBCK1 | RBFA | RBFOX1 | RBFOX2 | RBFOX3 | RBIS | RBKS | RBL1 | RBL2 | RBM10 | RBM11 | RBM12 | RBM12B | RBM14 | RBM14-RBM4 | RBM15 | RBM15-AS1 | RBM15B | RBM17 | RBM17P1 | RBM18 | RBM19 | RBM20 | RBM22 | RBM22P1 | RBM23 | RBM24 | RBM25 | RBM26 | RBM26-AS1 | RBM27 | RBM28 | RBM3 | RBM33 | RBM34 | RBM38 | RBM39 | RBM4 | RBM41 | RBM42 | RBM43 | RBM43P1 | RBM44 | RBM45 | RBM46 | RBM47 | RBM48 | RBM48P1 | RBM4B | RBM5 | RBM5-AS1 | RBM6 | RBM7 | RBM8A | RBMS1 | RBMS1P1 | RBMS2 | RBMS2P1 | RBMS3 | RBMS3-AS3 | RBMX | RBMX2 | RBMX2P1 | RBMXL1 | RBMXL2 | RBMXL3 | RBMY1A1 | RBMY1B | RBMY1D | RBMY1F | RBMY1J | RBMY2EP | RBMY2FP | RBP1 | RBP2 | RBP3 | RBP4 | RBP5 | RBP7 | RBPJ